As researchers continue to elucidate the roles of IL-1 in viral infection and other hyperinflammatory conditions, anakinra and similar agents may become integral components of treatment protocols aimed at controlling excessive inflammatory responses. This evidence concerns the gene IL1B and viral infectious disease.